Document is current
Any future updates will be listed below
-
Authors
Meder, Lydia https://orcid.org/0000-0002-9547-5812
Orschel, Charlotte I.
Bouchez, Cyrielle L.
Gholamipoorfard, Rahil
Orschel, Claudia V.
Stahl, David
Kreer, Christoph https://orcid.org/0000-0002-9140-9850
Koker, Mirjam
Nill, Marieke
Kocak, Ilayda G.
Noh, Ka-Won
Zhao, Xinlei
Ullrich, Leon https://orcid.org/0000-0002-4358-0717
Häupl, Björn
Jakob, Josefine
Eich, Marie-Lisa
Florin, Alexandra
Grüll, Holger
Wolf, Jürgen
Beleggia, Filippo https://orcid.org/0000-0003-0234-7094
Büttner, Reinhard https://orcid.org/0000-0001-8806-4786
Oellerich, Thomas
Klein, Florian https://orcid.org/0000-0003-1376-1792
Brägelmann, Johannes https://orcid.org/0000-0002-1306-2169
Reinhardt, H. Christian https://orcid.org/0000-0001-5706-9349
Abedpour, Nima https://orcid.org/0000-0002-2933-8035
Ullrich, Roland T.
-
Funding
Funding for this research was provided by:
Wilhelm Sander-Stiftung (R2024.171.1)
Deutsche Forschungsgemeinschaft (UL379/1-1, CRC-1530/B05, GRK 3110/1, CRC1310/project ID 325931972, CRC-1399/A01/C02, CRC1310/project ID 325931972, CRC-1399/ project ID 413326622, CRC1310/project ID 325931972, CRC-1399/A01/C02, 497777992, GRK 3110/1)
Deutsche Krebshilfe (70113307, 70113307, 70113307, 70113307, 70114593)
Fritz Thyssen Stiftung (10.21.1.026MN)
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 14 November 2025
First Online: 9 December 2025
Competing interests
: H.C.R. received consulting and lecture fees from Abbvie, Roche, KinSea, Vitis, Cerus, Lilly, Novartis, Takeda, AstraZeneca, Vertex, and Merck. H.C.R. received research funding from AstraZeneca and Gilead Pharmaceuticals. H.C.R. is a co-founder of CDL Therapeutics GmbH. J.B. has received research funding from Bayer and travel grants by Merck and Bicycle Therapeutics outside of the submitted work. T.O. received research funding from Gilead and Merck KGaA, is a consultant/received honoraria for/from Beigene, Roche, Janssen, Merck KGaA, Gilead, Kronos Bio and Abbvie (all not related to this work). The remaining authors declare no conflicting interests. J.B. has received research funding from Bayer outside of the submitted work. The remaining authors declare no competing interests.
